ArticleMolecular genetics & genomic medicine2026
Prenatal Diagnosis and Functional Analysis of Two Compound Heterozygous Variants in the KLHL40 Gene Causing Nemaline Myopathy 8.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Congenital Clubfoot as an Early Manifestation of Duchenne Muscular Dystrophy?Muscles (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundNemaline myopathy (NEM) is a rare congenital muscular disorder characterized by slow progression or static neuromuscular symptoms, which is mainly caused by variants in genes encoding the myofilament protein of skeletal muscle sarcomere. This study aimed to conduct prenatal diagnosis and functional analysis of variants in the KLHL40 gene causing NEM 8.
methodsA Chinese family who experienced multiple pregnancies with recurrent prenatal ultrasound anomalies (such as clubfoot and polyhydramnios) and subsequent neonatal death was enrolled in this study. Etiology diagnosis was conducted using karyotype, chromosomal microarray analysis (CMA), and exome sequencing (ES). Quantitative real-time reverse transcription polymerase chain reaction (qPCR) and western blotting were performed to investigate the transcription and expression levels of the defective gene. Hematoxylin-eosin (HE) stain and modified Gomori staining were used for further pathological examination.
resultsNo chromosomal abnormalities were detected by karyotype and CMA in the proband of this family. However, the ES results revealed two compound heterozygous variants in KLHL40 gene NM_152393.4:c.[1516A> C p.(T506P)]; [1327G> A p.(G443S)] in the fetus. The c.1516A> C p.(T506P) variant was interpreted as pathogenic, whereas the p.G443S variant was rarely reported and classified as a variant of uncertain significance. Interestingly, the subsequent western blotting analysis elicited a significantly decreased expression level of KLHL40 protein in fetal skeletal muscle tissues compared with the controls. In addition, the HE and modified Gomori stains demonstrated nemaline bodies in the fetus using skeletal muscle tissue.
conclusionCombining prenatal ultrasound and ES testing increases diagnostic yield among NEM-affected fetuses. Our results extend the mutational spectrum of the pathogenic KLHL40 variant c.1327G> A p.(G443S) linked to NEM8 and aid genotype-phenotype correlation analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.